Gilead has returned the rights to…
Gilead has returned the rights to a cancer candidate it [...]
Keros has shaken up its leadership…
Keros has shaken up its leadership structure as the biotech [...]
As other pharmas drop next-gen…
As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental [...]
The Trump administration has…
The Trump administration has broken the law by withholding funds [...]
Alltrna, the preclinical Flagship…
Alltrna, the preclinical Flagship Pioneering-backed biotech trying to turn transfer [...]
Contineum Therapeutics has pumped…
Contineum Therapeutics has pumped the brakes on two projects, freeing [...]
The Department of Health and Human…
The Department of Health and Human Services has announced a [...]
As part of a “strategic alignment”…
As part of a “strategic alignment” of its pipeline, BioNTech [...]
While the ex-Sanofi molecule…
While the ex-Sanofi molecule failed to move the needle in [...]
Vertex Pharmaceuticals has hit a…
Vertex Pharmaceuticals has hit a snag in its efforts to [...]